| Literature DB >> 26884166 |
Mariko L Bennett1, F Chris Bennett2, Shane A Liddelow3, Bahareh Ajami4, Jennifer L Zamanian5, Nathaniel B Fernhoff6, Sara B Mulinyawe5, Christopher J Bohlen5, Aykezar Adil5, Andrew Tucker5, Irving L Weissman6, Edward F Chang7, Gordon Li8, Gerald A Grant8, Melanie G Hayden Gephart8, Ben A Barres1.
Abstract
The specific function of microglia, the tissue resident macrophages of the brain and spinal cord, has been difficult to ascertain because of a lack of tools to distinguish microglia from other immune cells, thereby limiting specific immunostaining, purification, and manipulation. Because of their unique developmental origins and predicted functions, the distinction of microglia from other myeloid cells is critically important for understanding brain development and disease; better tools would greatly facilitate studies of microglia function in the developing, adult, and injured CNS. Here, we identify transmembrane protein 119 (Tmem119), a cell-surface protein of unknown function, as a highly expressed microglia-specific marker in both mouse and human. We developed monoclonal antibodies to its intracellular and extracellular domains that enable the immunostaining of microglia in histological sections in healthy and diseased brains, as well as isolation of pure nonactivated microglia by FACS. Using our antibodies, we provide, to our knowledge, the first RNAseq profiles of highly pure mouse microglia during development and after an immune challenge. We used these to demonstrate that mouse microglia mature by the second postnatal week and to predict novel microglial functions. Together, we anticipate these resources will be valuable for the future study and understanding of microglia in health and disease.Entities:
Keywords: RNAseq; developmental neuroscience; glia; macrophage; microglia
Mesh:
Substances:
Year: 2016 PMID: 26884166 PMCID: PMC4812770 DOI: 10.1073/pnas.1525528113
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205